The paediatric response to the SARS-COV-2 virus and what we can learn from it (Record no. 76090)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02105nim a2200529 a 4500 |
001 - CONTROL NUMBER | |
control field | HST8150 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | UkLoHST |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
fixed length control field | m o h |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | cr nna|||||||| |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | sr |mnnnnnzne| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200404s2020 enk|||||o||h||||||||eng d |
028 50 - PUBLISHER NUMBER | |
Publisher number | 8150 |
Source | Henry Stewart Talks |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (UkLoHST)4224 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | UkLoHST |
Language of cataloging | eng |
Transcribing agency | UkLoHST |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Permar, Sallie, |
Affiliation | (Duke University Medical School, USA) |
Relator code | spk |
245 14 - TITLE STATEMENT | |
Title | The paediatric response to the SARS-COV-2 virus and what we can learn from it |
Medium | [electronic resource] / |
Statement of responsibility, etc. | Sallie Permar. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
Place of publication, distribution, etc. | London : |
Name of publisher, distributor, etc. | Henry Stewart Talks, |
Date of publication, distribution, etc. | 2020. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1 online resource (1 streaming audio file (16 min.)). |
490 1# - SERIES STATEMENT | |
Series statement | Interviews on Covid-19, |
International Standard Serial Number | 2056-452X |
500 ## - GENERAL NOTE | |
General note | Audio interview. |
500 ## - GENERAL NOTE | |
General note | Title from title frames. |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Contents: Current hypotheses on why children are less effected by COVID-19 than older individuals -- How this knowledge might benefit the treatment of older individuals -- Safety during related research -- The implications of this knowledge on vaccine development -- Future considerations for vaccine development. |
506 ## - RESTRICTIONS ON ACCESS NOTE | |
Terms governing access | Access restricted to subscribers. |
538 ## - SYSTEM DETAILS NOTE | |
System details note | Mode of access: World Wide Web. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Children |
General subdivision | Diseases. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Coronavirus infections |
General subdivision | Immunological aspects. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Coronaviruses. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | COVID-19 (Disease) |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Immunity. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Older people |
General subdivision | Diseases. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Vaccines |
General subdivision | Development. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Age Factors. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Betacoronavirus. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Child. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Coronavirus Infections. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | COVID-19 Vaccines. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | COVID-19 |
General subdivision | drug therapy. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | COVID-19 |
General subdivision | immunology. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Disease Susceptibility. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Drug Development. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Patient Safety. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | SARS-CoV-2. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Vaccination. |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
Uniform title | Henry Stewart talks. |
Name of part/section of a work | Biomedical & life sciences collection. |
-- | Interviews on Covid-19. |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://hstalks.com/bs/4224/">https://hstalks.com/bs/4224/</a> |
856 42 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://hstalks.com/bs/p/1060/">https://hstalks.com/bs/p/1060/</a> |
Materials specified | Series |
No items available.